CMS Memo
CMS Releases new Memo
In keeping with MEDVAL's policy of not releasing frantic blast emails and instant analysis whenever CMS decides to issue a new WCMSA memo, we are going to post it here for safekeeping.
CMS MEMO 5-14-2010
After we have a chance to analyze the information and consider the theoretical and practical implications, we will post our thoughts for anyone that cares.
Ok, a little instant analysis for those that simply cannot wait.
1. This will reduce MSA amount. By how much we do not know just yet
2. It will reduce settlement amounts on excludable drugs since they can use other pricing methodologies and/or durations
3. The rated age portion proves once again that CMS has no idea what a rated age is or isn't
4. Expect a bevy of blast emails from MSA industry "insiders" who claim to have been the cause of new memo based on "working" with CMS
Posted by Medicare Set Aside Services at 5/14/2010 6:31 PM 
Categories: CMS Memos
Tags: Medicare Set-Aside CMS Memo
Categories: CMS Memos
Tags: Medicare Set-Aside CMS Memo
It appears PMSI is taking ALL the credit for CMS's policy revision. Here is their blast email.
Hi xxxx,
I am a National Sales Executive with PMSI Settlement Solutions specializing in Workers' Compensation and Liability claims.
I am sending this email to share our exciting news with you...
We did it! CMS has adopted our first four criteria for appropriately allocating future pharmacy in MSA's. As you may be aware we have been advocating on behalf of the industry with CMS for the past year and the only MSA vendor that has been calculating pharmacy in MSA's using the methodology CMS has recently accepted since June of last year.
We are ecstatic; as I am sure you will be as well. See attached for more details.
Also per the memo, we can re-submit MSA's on cases that have not settled yet!! So we can do the DVR on any of your in-house MSA's that have high pharmacy costs and either we can resubmit for approval, or you can provide our DVR and re-submit.
Please let me know if you have any questions on Cost Savings utilizing PMSI's Drug Value Review.
Warm Regards,
xxxxxxxx
PMSI Settlement SolutionsSM
National Sales Executive
Reply to this